PMID: 7540594Mar 1, 1995Paper

Bone marrow stroma-dependent modulation of CD45R isoform expression on Abelson virus transformed pre-B cells

Immunological Investigations
M Fizzotti, S S Clark

Abstract

The CD45 glycoprotein family exhibits cell-lineage-associated structural heterogeneity which is due, in part, to alternative pre-mRNA splicing. The Abelson murine leukemia (A-MuLV) preferentially transforms immature B cells that express a B-cell-specific high molecular weight CD45 isoform, called B220. However, we observed that A-MuLV-transformed cell lines are often B220- while maintaining high levels of "pan" CD45 expression. In vitro transformation of murine bone marrow revealed that the stromal microenvironment over which A-MuLV-transformed lymphoblasts are grown affected the B220 phenotype of the pre-B cells. Over a period of a few weeks, B220+ populations grown over a clonal stromal cell line gradually became B220-. However, the transition from a B220+ to B220- phenotype was dependent on the lot of fetal calf serum used. In contrast, cells grown over a heterogeneous bone marrow stroma maintained B220+ expression for long periods of time. The appearance of B220- cells in clonal B220+ populations indicated that the change in phenotype resulted in part from modulation of B220 expression. B220- B-cell lines did not express the high molecular weight CD45 RNA species indicating that the B220- phenotype was due to alternative pr...Continue Reading

References

Oct 1, 1979·The Journal of Experimental Medicine·H Westen, D F Bainton
Jan 1, 1992·Developmental Immunology·J D BretzR C Schwartz
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·Y SagaE A Boyse
May 1, 1990·Clinical and Experimental Immunology·V AsensiK Nomoto
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G ShaulskyV Rotter
Nov 8, 1990·Nature·E B Bell, S M Sparshott
Jan 1, 1990·Immunogenetics·Y SagaE A Boyse
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A ScherleO N Witte
Jan 1, 1989·International Immunology·G S JensenL M Pilarski
Jul 1, 1986·European Journal of Immunology·P L WitteV Vĕtvicka
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J McLaughlinO N Witte
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P MauchS Hellman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.